Click a link below to view the mailing archive as if it had been sent to you.
| 2019-11-30 00:15 | | Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO and more... |
| 2019-11-28 00:15 | | Before 2019 closes, the FDA has 3 key approval decisions to make and more... |
| 2019-11-27 12:15 | | Chasing Mylan, Hikma tries again with rejected generic Advair in US and more... |
| 2019-11-27 00:15 | | Six Drug Companies Subpoenaed In Federal Opioid Investigation and more... |
| 2019-11-26 12:15 | | Teva, others talk settlements with feds in yearslong generics price fixing probe: report and more... |
| 2019-11-26 00:15 | | Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule and more... |
| 2019-11-25 12:15 | | La Jolla shares fall on CEO departure, clinical trial results and more... |
| 2019-11-25 00:15 | | Novartis buys Medicines Co. in $9.7B bet on cholesterol drug and more... |
| 2019-11-24 00:15 | | AstraZeneca CEO: Closing In On A Cancer Cure and more... |
| 2019-11-22 12:15 | | Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time and more... |
| 2019-11-22 00:15 | | With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M and more... |
| 2019-11-21 12:15 | | Hologic burns its aesthetics unit and more... |
| 2019-11-21 00:15 | | FDA's rapid review pace nets an early approval for Alnylam's second drug and more... |
| 2019-11-20 12:15 | | Lilly putting $400M into U.S. diabetes production, adding 100 jobs and more... |
| 2019-11-20 00:15 | | AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much and more... |
| 2019-11-19 12:15 | | Novo Ventures Sows $25M Into Accelerator to Break Into Illustrious Mass Bio Space and more... |
| 2019-11-19 00:15 | | Sharing clinical trial data: lessons from the YODA Project and more... |
| 2019-11-18 12:15 | | AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds and more... |
| 2019-11-18 00:15 | | Bone Tumors Stop Immunotherapy Working For Prostate Cancer and more... |
| 2019-11-17 00:15 | | AHA: AstraZeneca's Farxiga outcomes data looks even better in patients without diabetes and more... |
| 2019-11-16 12:15 | | Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug and more... |
| 2019-11-16 00:15 | | Thermo Fisher Rumored to Be Interested in Acquiring Qiagen and more... |
| 2019-11-15 12:15 | | Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous and more... |
| 2019-11-15 00:15 | | FDA Advisory Committee Votes Unanimously in Favor of Expanding Amarin’s Vascepa Label and more... |
| 2019-11-14 12:15 | | Apple launches virtual health studies aiming to enroll hundreds of thousands of customers and more... |
| 2019-11-14 00:15 | | FDA still allowing secret reports on medical devices and more... |
| 2019-11-13 12:15 | | Abbott Labs CEO Miles White Stepping Down After Two Decades and more... |
| 2019-11-13 00:15 | | FDA grants breakthrough status to AI-based gastric cancer diagnostic and more... |
| 2019-11-12 12:15 | | AstraZeneca plans 2020 filing for anifrolumab in lupus and more... |
| 2019-11-12 00:15 | | FDA rejects Lipocine's testosterone drug for third time and more... |
| 2019-11-11 12:15 | | Breakthrough status and promise of a speedy review arrives for Opdivo/Yervoy combination as Bristol-Myers bites at Bayer and more... |
| 2019-11-11 00:15 | | Upcoming events – Axsome takes on migraine and Kala looks to dry eye again and more... |
| 2019-11-10 00:15 | | All-in-One Device Reduces the Number of Steps Needed for Diabetes Care and more... |
| 2019-11-09 00:15 | | Pfizer's 'brainstorming' payment deals as gene therapies advance |
| 2019-11-08 12:15 | | Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma and more... |
| 2019-11-08 00:15 | | Pharma Giant Teva Reported Lagging Earnings — Here's Why Shares Rallied and more... |
| 2019-11-07 12:15 | | Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S. and more... |
| 2019-11-07 00:15 | | Cadence Raises $15M in a Healthy and Growing Neuromodulation Market and more... |
| 2019-11-06 12:15 | | AstraZeneca creates $1B Chinese fund, vows to double R&D team and more... |
| 2019-11-06 00:15 | | China's Alzheimer’s Drug Approval Raises Hopes and Skepticism and more... |
| 2019-11-05 12:15 | | Sanofi’s Fluzone quadrivalent formulation gets FDA nod in older people and more... |
| 2019-11-05 00:15 | | #BIOSummit19 Concludes with Message of Hope Offered by Innovation and more... |
| 2019-11-04 12:15 | | Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut and more... |
| 2019-11-04 00:15 | | U.S. Sponsors Of Health Insurance Lack Evidence-Based Transparency In Formulary Decisions and more... |
| 2019-11-03 11:15 | | Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J and more... |
| 2019-11-03 00:15 | | Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J and more... |
| 2019-11-02 00:15 | | AbbVie says multiple parties vying for assets related to Allergan deal approval and more... |
| 2019-11-01 12:15 | | Trump will nominate MD Anderson’s Stephen Hahn to lead FDA today and more... |
| 2019-11-01 00:15 | | Merck again borrows Gardasil supplies from CDC and more... |
